528 related articles for article (PubMed ID: 17404779)
1. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
[TBL] [Abstract][Full Text] [Related]
2. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
Litvinenko IV; Krasakov IV; Tikhomirova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
[TBL] [Abstract][Full Text] [Related]
3. Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson's disease: a preliminary evidence.
Liguori C; Fernandes M; Cerroni R; Ludovisi R; Mercuri NB; Stefani A; Pierantozzi M
Neurol Sci; 2022 Sep; 43(9):5355-5362. PubMed ID: 35536495
[TBL] [Abstract][Full Text] [Related]
4. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
[TBL] [Abstract][Full Text] [Related]
5. Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
Pierantozzi M; Placidi F; Liguori C; Albanese M; Imbriani P; Marciani MG; Mercuri NB; Stanzione P; Stefani A
Sleep Med; 2016 May; 21():140-4. PubMed ID: 27448485
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography.
Uemura Y; Nomura T; Inoue Y; Yamawaki M; Yasui K; Nakashima K
J Neurol Sci; 2009 Dec; 287(1-2):36-40. PubMed ID: 19804890
[TBL] [Abstract][Full Text] [Related]
7. Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease.
Nunes DM; Mota RM; Machado MO; Pereira ED; Bruin VM; Bruin PF
Braz J Med Biol Res; 2008 Oct; 41(10):926-31. PubMed ID: 19030713
[TBL] [Abstract][Full Text] [Related]
8. Sleep quality, excessive daytime sleepiness, and depression in Parkinson's disease: implications for improved patient outcomes.
Kobak Tur E; Demir M; Kenangil G; Mayda Domaç F
Neurol Res; 2024 Apr; 46(4):297-303. PubMed ID: 38264903
[TBL] [Abstract][Full Text] [Related]
9. Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.
Schrempf W; Fauser M; Wienecke M; Brown S; Maaß A; Ossig C; Otto K; Brandt MD; Löhle M; Schwanebeck U; Graehlert X; Reichmann H; Storch A
Eur J Neurol; 2018 Apr; 25(4):672-679. PubMed ID: 29322594
[TBL] [Abstract][Full Text] [Related]
10. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
[TBL] [Abstract][Full Text] [Related]
12. Impact of sleep quality on the quality of life of patients with Parkinson's disease: a questionnaire based study.
Pandey S; Bajaj BK; Wadhwa A; Anand KS
Clin Neurol Neurosurg; 2016 Sep; 148():29-34. PubMed ID: 27372436
[TBL] [Abstract][Full Text] [Related]
13. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.
Videnovic A; Noble C; Reid KJ; Peng J; Turek FW; Marconi A; Rademaker AW; Simuni T; Zadikoff C; Zee PC
JAMA Neurol; 2014 Apr; 71(4):463-9. PubMed ID: 24566763
[TBL] [Abstract][Full Text] [Related]
14. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
Liguori C; Mercuri NB; Albanese M; Olivola E; Stefani A; Pierantozzi M
J Neurol; 2019 Mar; 266(3):636-641. PubMed ID: 30607535
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of sleep disorders in patients with Parkinson's disease.
Mao ZJ; Liu CC; Ji SQ; Yang QM; Ye HX; Han HY; Xue Z
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):100-104. PubMed ID: 28224427
[TBL] [Abstract][Full Text] [Related]
16. Melatonin for sleep disturbances in Parkinson's disease.
Dowling GA; Mastick J; Colling E; Carter JH; Singer CM; Aminoff MJ
Sleep Med; 2005 Sep; 6(5):459-66. PubMed ID: 16084125
[TBL] [Abstract][Full Text] [Related]
17. [The factors impact on the urgent daytime sleepiness degree in the Parkinson's disease].
Nodel MR; Shevtsova KV; Kovrov GV
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):102-108. PubMed ID: 36279235
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial.
Hadi F; Agah E; Tavanbakhsh S; Mirsepassi Z; Mousavi SV; Talachi N; Tafakhori A; Aghamollaii V
Neurol Sci; 2022 Oct; 43(10):6141-6148. PubMed ID: 35660990
[TBL] [Abstract][Full Text] [Related]
19. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
[TBL] [Abstract][Full Text] [Related]
20. Sleep disturbances in Taiwanese patients with Parkinson's disease.
Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J
Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
